Mythic, an AI chip developer that emerged out of UM, has closed a $40m round led by SoftBank Ventures that included another corporate venturing unit, Lockheed Martin Ventures.

Monsanto Growth Ventures has co-led the first round disclosed by Pairwise Plants, an agricultural gene-editing company based on Harvard University research.

Illumina Ventures has led a series A1 round for Cernostics, a cancer diagnostics company that has now raised $13m from backers including UPMC Enterprises.

Appulse Power, a spinout from University of Toronto, has been acquired by Silanna Semiconductor for an undisclosed sum.

SUNY Downstate spinout Concarlo is working on tests to establish the suitability of breast cancer patients for a therapy known as CDK4 inhibitor treatment.

Qubis has backed Causeway's bid to create a nanochip-powered sensor that would help prevent ineffective antibiotic prescriptions.

Boston Scientific has bought Emcision, a spinout from Imperial College London that is developing a range of surgical instruments.

The cancer immunotherapy developer, backed by Stanford University, has closed the offering after the underwriters bought another $18m of shares.

The Lund University spinout, which is working on diagnostics technology for applications in oncology, will use the proceeds to pursue a recruitment drive.